Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling

NeuroImage: Clinical

Volumn 3, Issue , 2013, Pages 171-179

  Jones, Blake C ^a,b   Nair, Govind ^a   Shea, Colin D ^a   Crainiceanu, Ciprian M ^c   Cortese, Irene C M ^a   Reich, Daniel S ^a,c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Brain atrophy; Heterogeneous data; Mixed effects model; MRI; Multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CALCULATION; CEREBROSPINAL FLUID; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THERAPY EFFECT; WHITE MATTER;

EID: 84883353846     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2013.08.001     Document Type: Article

References (42)

1. D.R. Altmann, B. Jasperse, F. Barkhof, K. Beckmann, M. Filippi, and L.D. Kappos Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis Neurology 72 2009 595 601
2. V.M. Anderson, J.W. Bartlett, N.C. Fox, L. Fisniku, and D.H. Miller Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates Journal of Neurology 254 2007 1588 1594
3. R. Antulov, D.A. Carone, J. Bruce, V. Yella, M.G. Dwyer, and C.W. Tjoa Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis Journal of Neuroimaging 21 2011 210 218
4. D. Bates, M. Maechler, and B. Bolker lme4: Linear Mixed-effects Models Using S4 Classes 2011
5. I. Borges, C. Shea, J. Ohayon, B. Jones, R. Stone, and J. Ostuni The effect of daclizumab on brain atrophy in relapsing-remitting MS Multiple Sclerosis and Related Disorders 2 2013 133 140
6. A. Carass, M.B. Wheeler, J.L. Cuzzocreo, P.-L. Bazin, S.S. Bassett, and J.L. Prince A joint registration and segmentation approach to skull stripping Proceedings of the IEEE International Symposium on Biomedical Imaging 2007 656 659
7. D. Chard, G. Parker, C. Griffin, A. Thompson, and D. Miller The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology Journal of Magnetic Resonance Imaging 15 2002 259 267
8. A. Cnaan, N.M. Laird, and P. Slasor Tutorial in biostatistics: using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data Statistics in Medicine 16 1997 2349 2380
9. N. De Stefano, A. Giorgio, M. Battaglini, M. Rovaris, M.P. Sormani, and F. Barkhof Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes Neurology 74 2010 1868 1876
10. P. Diggle, S.L. Zeger, K.-Y. Liang, and P. Heagerty Analysis of longitudinal data A.C. Atkinson, J.B. Copas, D.A. Pierce, M.J. Schervish, R.J. Carroll, D.J. Hand, Oxford Statistical Science Series 2002 Oxford University Press 379
11. M. Dwyer, N. Bergsland, and R. Zivadinov Improved longitudinal gray matter atrophy assessment via a combination of SIENA and a 4-dimensional hidden Markov random field model Proc. ISMRM vol. 21 2013 3014 (Salt Lake City, UT)
12. M. Filippi, D.W. Paty, L. Kappos, F. Barkhof, D.A. Compston, and A.J. Thompson Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study Neurology 45 1995 255 260
13. M. Filippi, M. Rovaris, M. Inglese, F. Barkhof, N. De Stefano, and S. Smith Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial Lancet 364 2004 1489 1496
14. E. Fisher, J.-C. Lee, K. Nakamura, and R.A. Rudick Gray matter atrophy in multiple sclerosis: a longitudinal study Annals of Neurology 64 2008 255 265
15. L.K. Fisniku, D.T. Chard, J.S. Jackson, V.M. Anderson, D.R. Altmann, and K.A. Miszkiel Gray matter atrophy is related to long-term disability in multiple sclerosis Annals of Neurology 64 2008 247 254
16. G. Fitzmaurice, N. Laird, and J. Ware Applied Longitudinal Analysis 2nd ed. 2011 John Wiley & Sons, Ltd. Hoboken, NJ
17. R.J. Fox, E. Fisher, J. Tkach, J.-C. Lee, J.A. Cohen, and R.A. Rudick Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications Multiple Sclerosis 11 2005 140 145
18. J. Furby, T. Hayton, D. Altmann, R. Brenner, J. Chataway, and K.J. Smith A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis Journal of Neurology 257 2010 1508 1516
19. A. Giorgio, M. Battaglini, S.M. Smith, and N. De Stefano Brain atrophy assessment in multiple sclerosis: importance and limitations Neuroimaging clinics of North America 18 2008 675 686
20. D. Horakova, M.G. Dwyer, E. Havrdova, J.L. Cox, O. Dolezal, and N. Bergsland Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study Journal of Neurological Sciences 282 2009 112 119
21. S. Hughes, T. Spelman, M. Trojano, A. Lugaresi, G. Izquierdo, and F. Grand'maison The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase registry Journal of Neurology, Neurosurgery & Psychiatry 83 2012 305 310
22. L. Kappos, D. Moeri, E.W. Radue, A. Schoetzau, K. Schweikert, and F. Barkhof Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis Lancet 353 1999 964 969
23. J. Martola, J. Bergström, S. Fredrikson, L. Stawiarz, J. Hillert, and Y. Zhang A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images Neuroradiology 52 2010 109 117
24. A. Mellanby, and M. Reveley Effects of acute dehydration on computerised tomographic assessment of cerebral density and ventricular volume Lancet 2 1982 874
25. D.H. Miller, D. Soon, K.T. Fernando, D.G. MacManus, G.J. Barker, and T.A. Yousry MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS Neurology 68 2007 1390 1401
26. P. Molyneux, L. Kappos, C. Polman, C. Pozzilli, F. Barkhof, and M. Filippi The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis Brain 123 2000 2256 2263
27. I. Pirko, C. Lucchinetti, S. Sriram, and R. Bakshi Gray matter involvement in multiple sclerosis Neurology 68 2007 634 642
28. C. Polman, S. Reingold, G. Edan, M. Filippi, H. Hartung, and L. Kappos Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria Annals of Neurology 58 2005 840 846
29. C.H. Polman, S.C. Reingold, B. Banwell, M. Clanet, J.A. Cohen, and M. Filippi Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Annals of Neurology 69 2011 292 302
30. R Development Core Team R: A Language and Environment for Statistical Computing 2011
31. A. Rao, N. Richert, T. Howard, B. Lewis, C. Bash, and H. McFarland Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNβ-1b Neurology 59 2002 688 694
32. S.D. Roosendaal, K. Bendfeldt, H. Vrenken, C.H. Polman, S. Borgwardt, and E.W. Radue Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability Multiple Sclerosis 17 2011 1098 1106
33. M. Rovaris, G. Comi, M.A. Rocca, J.S. Wolinsky, and M. Filippi Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications Brain 124 2001 1803 1812
34. M.P. Sampat, B.C. Healy, D.S. Meier, E. Dell'Oglio, M. Liguori, and C.R.G. Guttmann Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements NeuroImage 52 2010 1367 1373
35. N. Shiee, P.-L. Bazin, A. Ozturk, D.S. Reich, P.A. Calabresi, and D.L. Pham A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions NeuroImage 49 2010 1524 1535
36. N. Shiee, P.-L. Bazin, K.M. Zackowski, S.K. Farrell, D.M. Harrison, and S.D. Newsome Revisiting brain atrophy and its relationship to disability in multiple sclerosis PLoS One 7 2012 e37049
37. R.T. Shinohara, C.M. Crainiceanu, B.S. Caffo, M.I. Gaitán, and D.S. Reich Population-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosis NeuroImage 57 2011 1430 1446
38. A. Shirani, Y. Zhao, E. Kingwell, P. Rieckmann, and H. Tremlett Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009) Multiple Sclerosis 18 2012 442 450
39. J.G. Sled, A.P. Zijdenbos, and A.C. Evans A nonparametric method for automatic correction of intensity nonuniformity in MRI data IEEE Transactions on Medical Imaging 17 1998 87 97
40. S.M. Smith, Y. Zhang, M. Jenkinson, J. Chen, P.M. Matthews, and A. Federico Accurate, robust, and automated longitudinal and cross-sectional brain change analysis NeuroImage 17 2002 479 489
41. H. Wickham ggplot2: Elegant Graphics for Data Analysis 2009 Springer New York
42. R. Zivadinov, A.T. Reder, M. Filippi, A. Minagar, O. Stüve, and H. Lassmann Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis Neurology 71 2008 136 144